HAZLET, N.J. - s4story -- In this program, experts will discuss the risk factors for, and risks of hyperkalemia, treatment goals of  acute and chronic hyperkalemia, the importance of RAASi in CKD and HF patients, the potential adverse outcomes in individuals with ESRD undergoing adequate hemodialysis with predialysis hyperkalemia,  and evidence with K+ binders in various patient populations. A multi-specialty faculty, consisting of two nephrologists, a dietician, and a primary care physician, will then discuss cardiorenal challenges faced by family physicians, including dietary recommendations to their patients with hyperkalemia. In addition, the panel will identify key cardiorenal messages for patients taking K+ binders (for hyperkalemia) and sodium-glucose cotransporter 2 (SGLT2) inhibitors which reduce the risk for hyperkalemia and significantly improve cardiorenal outcomes.

More on S For Story

• $150 Million Financing Initiates N A S D A Q's First Tether Gold Treasury Combining the Stability of Physical Gold with Blockchain $AURE
• Podcast for Midlife Women Entrepreneurs Celebrates 100th Episode with Rhea Lana's Founder and CEO
• What If Help Could Come Before the Fall?
• Digi 995: Spookyverse — Unlocking the Multiverse of the Digiverse
• Fiction author re-imagines Acts of the Apostles with Female Apostles

Click here for more information

CHAIR

Csaba P. Kovesdy, MD
Fred Hatch Professor of Medicine
Director, Clinical Outcomes and Clinical Trials Program in Nephrology
University of Tennessee Health Science Center
Memphis VA Medical Center
Memphis, Tennessee

FACULTY

Deborah Clegg, PhD
Vice President for Research
Texas Tech University Health Sciences Center El Paso
Professor of Internal Medicine
Paul L. Foster School of Medicine El Paso, Texas

Jay Shubrook, DO
Professor, Primary Care Department
Touro University California College of Osteopathic Medicine
Vallejo, California

Bruce Spinowitz, MD
Associate Director, Nephrology
Vice Chairman, Medicine
New York-Presbyterian Queens
Professor of Clinical Medicine
Weill Cornell Medical College
New York, New York

This educational activity is intended for primary care physicians and other clinicians managing patients at risk for, and with hyperkalemia.

More on S For Story

• Combatting Commercial Clutter: Award-Winning Author Andrew Kooman Releases Gather for Advent
• OddsTrader Examines the NHL Presidents Trophy Curse: Why Regular-Season Success Rarely Leads to Playoff Glory
• Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"
• Coming Up this Weekend on CNBC Mike Milligan Joins Tom Hegna on "Financial Freedom with Tom Hegna"
• Parker Stone Unleashes the Highly Anticipated Dark Romance, "The Reluctant Heir," Out Today

Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certifi cate of completion as AANP accepts AMA PRA Category 1.5 Credits™ through its reciprocity agreements.

Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #AAFPFMX #hyperkalemia #physician #potassium #cardiorenal #diet